{
    "clinical_study": {
        "@rank": "139593", 
        "acronym": "TALOS", 
        "arm_group": [
            {
                "arm_group_label": "Selective Serotonin Reuptake Inhibitors", 
                "arm_group_type": "Active Comparator", 
                "description": "Intervention Drug: Citalopram"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Intervention Drug: Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Scientific evidence has indicated a positive effect of SSRI treatment (serotonin reuptake\n      inhibitors) after stroke, beyond its known antidepressant effect. We wish to conduct a\n      prospective, randomized, double blind, placebo controlled multi center study of the combined\n      neuroprotective and antithrombotic effects of SSRI treatment after stroke.\n\n      Hypotheses:\n\n      SSRI treatment commenced in the acute phase of stroke (day 0-7) protects against new\n      thromboembolic events and leads to better rehabilitation. 600 stroke patients will be\n      randomized in a 1:1 ratio.\n\n      The treatment and follow up period is 6 months. During these 6 months there will be 2\n      clinical follow up visits, one telephone control and one visit to evaluate compliance\n      regarding medication."
        }, 
        "brief_title": "The Efficacy of Citalopram Treatment in Acute Stroke", 
        "completion_date": {
            "#text": "July 2021", 
            "@type": "Anticipated"
        }, 
        "condition": "Stroke", 
        "condition_browse": {
            "mesh_term": [
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  First ever ischemic stroke\n\n          -  Age 18 years or above\n\n        Exclusion Criteria:\n\n          -  Hemorrhagic stroke\n\n          -  Dementia or other neurodegenerative disease\n\n          -  Antidepressant treatment within 6 months of admission\n\n          -  Acute need for antidepressant treatment\n\n          -  Drug abuse or other conditions that may indicate noncompliant behavior\n\n          -  Liver failure (increased liver enzyme levels up to or more than 2 times upper limit)\n\n          -  Renal failure (GFR under 30)\n\n          -  Hyponatremia (S-potassium below 130 mmol/l)\n\n          -  Actively bleeding ulcer\n\n          -  Fatal stroke or other severe co morbidity that markedly decreases expected life span\n\n          -  Prolonged QT interval (QTc above 500 ms)\n\n          -  Ongoing treatment with drugs known to prolong the QT interval"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01937182", 
            "org_study_id": "2013-002253-30"
        }, 
        "intervention": [
            {
                "arm_group_label": "Selective Serotonin Reuptake Inhibitors", 
                "description": "Citalopram 10-40 mg per day administered orally", 
                "intervention_name": "Citalopram", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Selective Serotonin Reuptake Inhibitors", 
                    "SSRI", 
                    "Seropram\u00ae"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "1/2-2 tablets per day with no intrinsic drug activity", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": [
                    "inactive drug", 
                    "inactive medicine", 
                    "inactive substance"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citalopram", 
                "Serotonin Uptake Inhibitors", 
                "Dexetimide", 
                "Serotonin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Stroke", 
            "SSRI", 
            "CT (computerized tomography)", 
            "MRI (Magnetic Resonance Imaging)"
        ], 
        "lastchanged_date": "April 2, 2014", 
        "location": [
            {
                "contact": {
                    "email": "boris.modrau@rn.dk", 
                    "last_name": "Boris Modrau, M.D.", 
                    "phone": "+45 98165927"
                }, 
                "facility": {
                    "address": {
                        "city": "Aalborg", 
                        "country": "Denmark", 
                        "zip": "9100"
                    }, 
                    "name": "Aalborg University Hospital, Department of Neurology"
                }, 
                "investigator": {
                    "last_name": "Boris Modrau, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "kriskrag@rm.dk", 
                    "last_name": "Kristian L Kraglund, M.D.", 
                    "phone": "+45 20739438"
                }, 
                "contact_backup": {
                    "email": "greander@rm.dk", 
                    "last_name": "Grethe Andersen, DSMc", 
                    "phone": "+45 78463294"
                }, 
                "facility": {
                    "address": {
                        "city": "Aarhus", 
                        "country": "Denmark", 
                        "zip": "8000"
                    }, 
                    "name": "Aarhus University Hospital, Department of Neurology"
                }, 
                "investigator": [
                    {
                        "last_name": "Kristian L Kraglund, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Grethe Andersen, DSMc", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Janne K Mortensen, M.D.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "heiv@regionh.dk", 
                    "last_name": "Helle Iversen, DSMc", 
                    "phone": "+45 38633400"
                }, 
                "facility": {
                    "address": {
                        "city": "Glostrup", 
                        "country": "Denmark", 
                        "zip": "2600"
                    }, 
                    "name": "Glostrup University Hospital, Department of Neurology"
                }, 
                "investigator": [
                    {
                        "last_name": "Helle Iversen, DSMc", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Sofie A Simonsen, M.D.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Efficacy of Citalopram Treatment in Acute Stroke", 
        "overall_contact": {
            "email": "kriskrag@rm.dk", 
            "last_name": "Kristian L Kraglund, M.D.", 
            "phone": "+4520739438"
        }, 
        "overall_contact_backup": {
            "email": "greander@rm.dk", 
            "last_name": "Grethe Andersen, DMSc", 
            "phone": "+4578463294"
        }, 
        "overall_official": [
            {
                "affiliation": "Aarhus University Hospital", 
                "last_name": "Grethe Andersen, DSMc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Aarhus University Hospital", 
                "last_name": "Kristian L Kraglund, M.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Aalborg Universityhospital", 
                "last_name": "Boris Modrau, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Glostrup University Hospital", 
                "last_name": "Helle Iversen, DSMc", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Combined vascular death, TIA/re-stroke and STEMI", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01937182"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Death of any cause", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Myocardial Infarction", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Re-stroke", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Bleeding complications", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Combined vascular death", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "SDMT and MMSE tests are performed", 
                "measure": "Cognitive abilities", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "University of Aarhus", 
        "sponsors": {
            "collaborator": {
                "agency": "Danish Council for Independent Research", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}